Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan-Apr;30(1):113-24.

[Study of vascular risk in Navarre: objectives and design. Prevalence of metabolic syndrome and of vascular risk factors]

[Article in Spanish]
Affiliations
  • PMID: 17491613
Free article

[Study of vascular risk in Navarre: objectives and design. Prevalence of metabolic syndrome and of vascular risk factors]

[Article in Spanish]
J J Viñes et al. An Sist Sanit Navar. 2007 Jan-Apr.
Free article

Abstract

Background: To determine in a representative sample of the population the prevalence of risk factors and metabolic syndrome; their association with sub-clinical atherosclerotic lesions and their impact on cardiocerebrovascular disease 10 years after.

Material and methods: (Phase 1) Cross sectional survey of a random sample stratified by age and sex of the population of Navarre aged between 35 and 84. Antecedents, risk factors, physical and analytical exploration. (Phase II) Ten year follow-up cohort study, in 500 exposed to MS and 500 not exposed persons, aged between 45 and 74 years; with an 82.25% power to detect a risk ratio of 2; with analytical and image markers of sub-clinical atherosclerosis. (Phase III) Follow up of vascular events at ten years.

Results: The subjects recruited were 6,553; excluded or not found 871; the final sample was 5,682 (2,644 men and 3,038 women); 4,168 (73,4%) took part in the study. The prevalence of MS was 22.1% (95%CI 20.5 - 23.7) for men and 17,2% (95%CI 15.8 - 18.5) for women. The main cardiovascular RF were high compared to other geographical areas except for HDL cholesterol. The rate was 8.5% (95%CI 7.4 - 9.6) for men and 1.7% (95%CI 1.3 - 2.2)

Conclusions: There are important differences in risk between sex, being worst for men. The high figures for HDL cholesterol and the low prevalence of MS might mean a lower risk of vascular events in Navarra.

PubMed Disclaimer

Similar articles

Cited by

  • Prevalence of Cardiovascular Risk Factors in Spain: A Systematic Review.
    Sacramento-Pacheco J, Sánchez-Gómez MB, Gómez-Salgado J, Novo-Muñoz MM, Duarte-Clíments G. Sacramento-Pacheco J, et al. J Clin Med. 2023 Nov 6;12(21):6944. doi: 10.3390/jcm12216944. J Clin Med. 2023. PMID: 37959409 Free PMC article. Review.
  • Validity of type 2 diabetes diagnosis in a population-based electronic health record database.
    Moreno-Iribas C, Sayon-Orea C, Delfrade J, Ardanaz E, Gorricho J, Burgui R, Nuin M, Guevara M. Moreno-Iribas C, et al. BMC Med Inform Decis Mak. 2017 Apr 8;17(1):34. doi: 10.1186/s12911-017-0439-z. BMC Med Inform Decis Mak. 2017. PMID: 28390396 Free PMC article.
  • Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, Toledo E, Moreno-Iribas C; RIVANA Study Investigators. Guembe MJ, et al. Cardiovasc Diabetol. 2020 Nov 22;19(1):195. doi: 10.1186/s12933-020-01166-6. Cardiovasc Diabetol. 2020. PMID: 33222691 Free PMC article.
  • [Prevalence, awareness, treatment and control of cardiovascular risk factors in the Extremadura population (Spain). HERMEX study].
    Félix-Redondo FJ, Fernández-Bergés D, Fernando Pérez J, Zaro MJ, García A, Lozano L, Sanz H, Grau M, Alvarez-Palacios P, Tejero V. Félix-Redondo FJ, et al. Aten Primaria. 2011 Aug;43(8):426-34. doi: 10.1016/j.aprim.2010.07.008. Epub 2011 Feb 24. Aten Primaria. 2011. PMID: 21349604 Free PMC article. Spanish.
  • Cohort profile: the CORDELIA study (Collaborative cOhorts Reassembled Data to study mEchanisms and Longterm Incidence of chronic diseAses).
    Hernáez Á, Camps-Vilaró A, Polo-Alonso S, Subirana I, Ramos R, de Cid R, Rodríguez-Artalejo F, Elosua R, Chirlaque MD, Amiano P, Bermúdez-López M, Guevara M, Cinza-Sanjurjo S, Sánchez MJ, de León AC, Laclaustra M, Rojo-Martínez G, Guembe-Suescun MJ, Pérez-Gómez B, Vega-Alonso T, Torán-Monserrat P, Lora-Pablos D, Huerta JM, Valdivielso JM, Dégano IR, Félix-Redondo FJ, Gandarillas AM, Valdés S, Mundet-Tuduri X, Sánchez PL, Martín-Sánchez V, Rigo F, Alonso-Sampedro M, Moreno-Iribas C, Martín-Escudero JC, Delgado E, Grau M, Urrutia I, Ovejero D, Quintela I, Martí-Lluch R, Blay N, Banegas JR, Tizón-Marcos H, Gómez JH, Aizpurua A, Castro-Boqué E, Delfrade J, Prieto-Díaz MÁ, Rodríguez-Barranco M, Almeida-González D, Moreno-Franco B, Oualla-Bachiri W, Sayón-Orea C, Plans-Beriso E, Lozano JE, López-Lifante VM, Cancelas-Navia P, Cabrera-Castro N, Cambray S, Zacarías-Pons L, Fernández-Bergés D, Donoso-Navarro E, Maldonado-Araque C, Franch-Nadal J, Dorado-Díaz PI, Villarín-Castro A, Frontera-Juan G, Gude F, Andueza N, Téllez-Plaza M, Ares-Blanco J, Cruz R, Ribas-Aulinas M, Barretina J, Guallar-Castillón P, Caínzos-Achirica M, Colorado-Yohar SM, Llorente A, Diaz-Tocados JM, Ardanaz E, Micó-Pér… See abstract for full author list ➔ Hernáez Á, et al. Eur J Epidemiol. 2025 May;40(5):581-599. doi: 10.1007/s10654-025-01229-6. Epub 2025 May 12. Eur J Epidemiol. 2025. PMID: 40353978 Free PMC article.

Publication types